SCOLR Pharma, Inc. - Investor Relations

Investors

Overview
Annual Reports
Current SEC Filings
    2007 SEC Filings
    2006 SEC Filings
    2005 SEC Filings
    2004 SEC Filings
    2003 SEC Filings
Corporate Governance
Investor FAQ

Current SEC Filings

6/24/08 -
Form 8-K

Exhibit 10.1, Standard Multi-Tenant Lease

6/5/08 -
Form 8-K

Exhibit 99.1, Investor Presentation

5/5/2008 -
Form 8-K

Exhibit 99.1, Investor Presentation

5/2/2008 -
Form 10-Q, For the Quarterly Period Ended March 31, 2008

Exhibit 31.1, Chief Executive Officer Certification
Exhibit 31.2, Chief Financial Officer Certification
Exhibit 32.1, Chief Executive Officer Certification
Exhibit 32.2, Chief Financial Officer Certification

5/2/2008 -
Form 8-K

Exhibit 99.1, Press Release
Exhibit 99.2, Earnings Release

4/25/2008 -
Schedule 14A Definitive Proxy Statement

4/16/2008 -
Form 8-K

Exhibit 10.1, Executive Employment Agreement
Exhibit 10.2, Executive Employment Agreement

3/11/2008 -
Form 10-K , For the fiscal year ended December 31, 2007

Exhibit 4.2, Certification of Designation of Series A Junior Participating Preferred Stock
Exhibit 4.4, Rights Agreement
Exhibit 10.3, Warrant Agreement
Exhibit 23.1, Consent of Grant Thornton LLP
Exhibit 31.1, Certification of Chief Executive Officer
Exhibit 31.2, Certification of Chief Financial Officer
Exhibit 32.1, Certification of Chief Executive Officer
Exhibit 32.2, Certification of Chief Financial Officer